ATAI
NASDAQ · Pharmaceuticals
Ataibeckley Inc
$7.35
+0.06 (+0.82%)
Open$7.31
Previous Close$7.29
Day High$7.37
Day Low$7.30
52W High$7.45
52W Low$3.27
Volume—
Avg Volume19.92M
Market Cap2.73B
P/E Ratio—
EPS$-2.18
SectorPharmaceuticals
Analyst Ratings
Hold
21 analysts
Price Target
+450.2% upside
Current
$7.35
$7.35
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.71M | 2.70M | 436.73M |
| Net Income | -1,080,588,339 | -1,191,899,115 | 64.85M |
| Profit Margin | -16,142.0% | -46,040.8% | 14.9% |
| EBITDA | -1,041,462,118 | -1,216,403,523 | 102.81M |
| Free Cash Flow | — | — | 81.44M |
| Rev Growth | +161.0% | -75.3% | -6.2% |
| Debt/Equity | — | 0.20 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |